Medanta Hospitals recorded a jump of 25 per cent year on year (YoY) in its total income of Rs 2,759 crores in FY23, while in Q4FY23 the income soared by 37 per cent to Rs 731 crore. The company's Profit After Tax for the January-March quarter registered a four-fold jump YoY to Rs 101 crore while for FY23 the PAT increased by 66.2 per cent YoY to be recorded at Rs 326 crore.
Read More
The Indian pharmaceutical major Sun Pharmaceutical Industries on Friday reported its financials for the fourth quarter and full year ending March 31, 2023. The company posted a net profit of Rs 1,984 crores in the January-March quarter against a net loss of Rs 2,277 crores recorded in Q4 last year. While for FY23 Sun Pharma reported a net profit of Rs 8,473 cores compared to Rs 3,272 crores for FY22 up by 158 per cent year on year
Read More
Biocon Biologics closed the year to end-March with revenue on a trajectory towards $1 billion, its CEO said on Wednesday, helped by strong sales in the US and Europe from the biosimilars business it bought last year from Viatris Inc
Read More
The omnichannel retail pharmacy said its consolidated net profit rose to 265.8 million rupees (USD 3.21 million) for the quarter ended March 31, from 117.3 million rupees a year ago
Read More
JB Pharma an Indian pharmaceutical company announced its financial results for the fourth quarter and year ended 31st March, 2022 on Wednesday. The company recorded revenue of Rs 762 crores in the fourth quarter ended 31st March 2023 against Rs 625 crores in Q4FY22 registering growth of 22 per cent YoY
Read More
Fortis Healthcare one of India's leading healthcare providers on Tuesday announced its audited consolidated financial results for the quarter and year ended March 31, 2023. The healthcare company has registered consolidated revenues of Rs1,643 crores, up by 19.2 per cent YoY in Q4FY23 against Rs 1,378 recorded in Q4FY22
Read More
Bangalore-based pharmaceutical company Biocon on Tuesday announced its consolidated financial results for the fourth quarter that ended 31st March 2023, the company registered a 58.6 per cent rise in its consolidated revenues from operations year on year. The company's consolidated revenue for the March quarter stood at Rs 3,928 crores against Rs 2,476 crores in the same quarter last year
Read More
Indraprastha Medical Corporation on Tuesday announced its January-March quarter results, the healthcare provider has clocked a Profit After Tax (PAT) of Rs 19.84 crores in quarter four of the financial year 2023, registering a jump of 30.5 per cent year on year against Rs 15.20 crores registered in the same quarter in FY2022
Read More
